HKSE:08372 (Hong Kong)
Â
Ordinary Shares
HK$
0.11
(+3.77%)
May 10
Business Description
Grand Brilliance Group Holdings Ltd
ISIN : KYG4136R1020
Share Class Description:
HKSE:08372: Ordinary SharesCompare
Compare
Traded in other countries / regions
08372.Hong Kong IPO Date
2018-03-29Description
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 22.25 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.24 | |||||
| Interest Coverage | 63.66 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.21 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.6 | |||||
| 3-Year EBITDA Growth Rate | -1.9 | |||||
| 3-Year EPS without NRI Growth Rate | -5.9 | |||||
| 3-Year FCF Growth Rate | -16 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.86 | |||||
| 9-Day RSI | 71.7 | |||||
| 14-Day RSI | 66.76 | |||||
| 6-1 Month Momentum % | 8.7 | |||||
| 12-1 Month Momentum % | 40.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.45 | |||||
| Quick Ratio | 5.62 | |||||
| Cash Ratio | 3.96 | |||||
| Days Inventory | 207.18 | |||||
| Days Sales Outstanding | 61.71 | |||||
| Days Payable | 51.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.77 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | -9.1 | |||||
| Forward Dividend Yield % | 3.77 | |||||
| 5-Year Yield-on-Cost % | 3.77 | |||||
| Shareholder Yield % | 5.66 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.11 | |||||
| Operating Margin % | 10.94 | |||||
| Net Margin % | 9.25 | |||||
| FCF Margin % | 14.82 | |||||
| ROE % | 8.12 | |||||
| ROA % | 7.03 | |||||
| ROIC % | 15.58 | |||||
| ROC (Joel Greenblatt) % | 29.75 | |||||
| ROCE % | 10.46 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.64 | |||||
| PE Ratio without NRI | 9.64 | |||||
| Price-to-Owner-Earnings | 7.57 | |||||
| PS Ratio | 1 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 0.92 | |||||
| Price-to-Free-Cash-Flow | 6.63 | |||||
| Price-to-Operating-Cash-Flow | 6.63 | |||||
| EV-to-EBIT | 3.3 | |||||
| EV-to-EBITDA | 3.3 | |||||
| EV-to-Revenue | 0.4 | |||||
| EV-to-FCF | 2.68 | |||||
| Price-to-Projected-FCF | 0.69 | |||||
| Price-to-Graham-Number | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
| Price-to-Net-Cash | 2.2 | |||||
| Earnings Yield (Greenblatt) % | 30.3 | |||||
| FCF Yield % | 14.85 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers